This study is in progress, not accepting new patients
A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)
Summary
- Eligibility
- for people ages 25-65 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Sage Therapeutics
- ID
- NCT05107128
- Phase
- Phase 2 Huntington's Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 178 study participants
- Last Updated